DOW JONES23,162.96+509.10 2.25%
S&P 5002,715.49+56.08 2.11%
NASDAQ8,053.96+166.70 2.11%

KeyBanc Maintains Overweight on HealthEquity, Lowers Price Target to $65

KeyBanc analyst Donald Hooker maintains HealthEquity (NASDAQ:HQY) with a Overweight and lowers the price target from $86 to $65.

Benzinga · 03/17/2020 10:14

KeyBanc analyst Donald Hooker maintains HealthEquity (NASDAQ:HQY) with a Overweight and lowers the price target from $86 to $65.